In vivo antitumor activity by 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalconein a solid human carcinoma xenograft model
Tipo de material:
TextoSeries ; Cancer Chemother Pharmacol, 56(1), p.70-74, 2005Trabajos contenidos: - Ye, Ch.L
- Liu, J.W
- Wei, D.Z
- Lu, Y.H
- Qian, F
| Item type | Current library | Collection | Call number | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|
Documentos solicitados
|
CICY Documento préstamo interbibliotecario | Ref1 | B-7145 (Browse shelf(Opens below)) | Available |
Previously we have shown that 2¢,4¢-dihydroxy- 6'-methoxy-3',5'-dimethylchalcone (DMC), which is isolated from the buds of Cleistocalyx operculatus, significantly inhibits the growth of human liver cancer SMMC-7721 cells and is able to induce apoptosis of SMMC-7721 cells in vitro. Here we report the antitumor effects of DMC in vivo, using a solid human tumor xenograft mouse model using human liver cancer SMMC-7721 cells. The average tumor weights in the control group and in mice injected with 150 mg/kg DMC were 1.42±0.11 g and 0.59±0.12 g, respectively. Flow cytometric analysis of the tumor cell population demonstrated an aneuploid peak (representing 33.60±0.80
There are no comments on this title.
